ライフサイエンスコーパス: operable

1 egions indicating that repair mechanisms are operable.

2 th acid and base catalyzed mechanisms may be operable.

3 uggest that a reductive quenching pathway is operable.

4 ve quenching pathway of the photocatalyst is operable.

5 and 6151 (80%) cases that were high-risk but operable.

6 luded thrombophilic disorder in 31.9% (37.1% operable, 23.5% nonoperable) and splenectomy in 3.4% of

7 mptoms; 427 patients (62.9%) were considered operable, 247 (36.4%) nonoperable, and 5 (0.7%) had no o

8 e) and splenectomy in 3.4% of patients (1.9% operable, 5.7% nonoperable).

9 rterial hypertension-targeted therapy (28.3% operable, 53.8% nonoperable).

10 sm was reported for 74.8% of patients (77.5% operable, 70.0% nonoperable).

11 1350 patients with operable adenocarcinoma of the rectum were randomly assi

12 isease, because it renders inoperable tumors operable and increases the rates of breast-conserving su

13 spite similarities in clinical presentation, operable and nonoperable CTEPH patients may have distinc

14 tries, and a substantial number of patients (operable and nonoperable) receive off-label pulmonary ar

15 ant features of gene fusion data in an inter-operable and query-able fashion that will enable biologi

16 the relief of glucose repression is already operable at much higher glucose concentrations than is w

17 nanoscale magnetic resonance imaging that is operable at room temperature.

18 ng a low HTT solid-phase formation mechanism operable at temperatures commonly used for industrial bi

19 ntrally confirmed HER2-positive stage II-III operable breast cancer (>2 cm tumour size), an Eastern C

20 NAC for operable breast cancer (BC) can downstage disease and fa

21 Women with operable breast cancer (N = 2,411) were randomly assigne

22 Preoperative systemic therapy (PST) in operable breast cancer allows a small increase in breast

23 cycles of AC alone in patients with resected operable breast cancer and histologically positive axill

24 After surgical treatment, 3,121 women with operable breast cancer and involved lymph nodes were ran

25 Women with operable breast cancer and multicentric tumors, with duc

26 Women with operable breast cancer and multicentric tumors, with duc

27 and preclinical and clinical data of PST in operable breast cancer and the potential role of interme

28 for the different clinical presentations of operable breast cancer and to present quantitative progn

29 s from adjuvant therapies in such women with operable breast cancer are unknown.

30 Chinese women with hormone receptor-positive operable breast cancer benefit from adjuvant treatment w

31 Chemotherapy for operable breast cancer decreases the risk of death.

32 receptor-positive, lymph node-positive, and operable breast cancer for which they had undergone loca

33 Preoperative chemotherapy in operable breast cancer has been shown to improve breast

34 ng use of neoadjuvant chemotherapy (NAC) for operable breast cancer has raised questions about optima

35 dronate trials in different populations with operable breast cancer have been mixed.

36 clinical trials (RCTs) of PST for palpable, operable breast cancer have been reported since 1991 (fr

37 d well tolerated as tamoxifen in ER-positive operable breast cancer in postmenopausal women, but the

38 pants in this phase III randomized study had operable breast cancer involving four or more axillary l

39 In premenopausal women with operable breast cancer not selected for estrogen recepto

40 ous even within clinically similar groups of operable breast cancer patients.

41 We deemed eligible all patients with operable breast cancer presenting at The University of T

42 Systemic chemotherapy for operable breast cancer substantially decreases the risk

43 All patients with operable breast cancer that were eligible for a SLNB fro

44 9, we recruited 709 premenopausal women with operable breast cancer to a multisite randomized clinica

45 ide treatment in patients with HER2-positive operable breast cancer to determine whether there would

46 ve or high-risk node-negative HER2-positive, operable breast cancer to receive either pertuzumab or p

47 pants comprised 53 015 patients with primary operable breast cancer treated from 2003 to 2012.

48 res for individual patients with HR-positive operable breast cancer treated with chemohormonal therap

49 In all, 4,046 patients with HER2-positive operable breast cancer were enrolled to receive doxorubi

50 Patients with HER2-positive operable breast cancer were randomly assigned to doxorub

51 two patients with HER2-positive disease with operable breast cancer were randomly assigned to either

52 and operable or locally advanced potentially operable breast cancer were randomly assigned to neoadju

53 survival among patients with HER2-positive, operable breast cancer when it was added to trastuzumab

54 Patients with operable breast cancer with 0 to 3 positive nodes were e

55 Women diagnosed with operable breast cancer within 3 months underwent FDG-PET

56 seem to provide any benefit to patients with operable breast cancer, and should not change clinical p

57 med node-positive or high-risk node-negative operable breast cancer, had undergone complete excision,

58 Clodronate, given to patients with primary operable breast cancer, may reduce the occurrence of bon

59 In operable breast cancer, preoperative systemic therapy is

60 In operable breast cancer, there seems to be no survival ad

61 c (modified to stage 2-3c in February, 2010) operable breast cancer, who had completed neoadjuvant an

62 ed disease-free survival compared with AC in operable breast cancer.

63 is being used with increasing frequency for operable breast cancer.

64 redicted for improved survival in women with operable breast cancer.

65 bareolar technique for SLNB in patients with operable breast cancer.

66 d clinical and pathologic response rates for operable breast cancer.

67 ease-free and overall survival of women with operable breast cancer.

68 linical stage, and lymph node involvement in operable breast cancer.

69 follow-up of 24 years from the diagnosis of operable breast cancer.

70 cular invasion and early tumor metastasis in operable breast cancer.

71 ausal women with node-positive, ER-positive, operable breast cancer.

72 associated with poor outcomes in women with operable breast cancer.

73 al growth factor receptor 2 (HER2) -negative operable breast cancer.

74 and ER expression in patients with primary, operable breast cancer.

75 would improve relapse-free survival (RFS) in operable breast cancer.

76 eceptor 2 (HER2) -positive, stage II to IIIA operable breast cancer.

77 tdiagnosis among 53 premenopausal women with operable breast carcinoma.

78 uding whether concomitant treatment of TR in operable but high-risk patients with aortic stenosis is

79 ure, causes and obstacles that may have been operable but were not found in the literature were also

80 g force for substrate oxidation, an ET/PT is operable, but once ET (i.e., substrate one-electron oxid

81 The method is easily operable by a single person from a small boat, and the s

82 Clinical trials supported the thesis that operable cancer is a systemic disease and that variation

83 ould substantially increase CTC detection in operable cancer patients.

84 iated with reduced survival in patients with operable cancer.

85 ion based prognostic scores in patients with operable cancers.

86 hypertensive medical therapy (PHT) exists in operable candidates.

87 lymph node metastasis and poor prognosis in operable cases of pancreatic ductal adenocarcinoma (PDAC

88 of cetuximab to chemotherapy and surgery for operable colorectal liver metastases in KRAS exon 2 wild

89 steatosis, and the host SIR in patients with operable CRC.

90 s four of five studies of only patients with operable disease showed no significant relation.

91 In patients of low operative risk and operable disease, surgery should be considered to improv

92 ing evaluated in patients with earlier-stage operable disease.

93 ith node-positive or high-risk node-negative operable early breast cancer were randomly assigned by c

94 extended to include patients with large but operable early-stage breast cancer, with the possibility

95 eoperative chemotherapy improves survival in operable esophageal cancer and should be considered as a

96 th surgery alone for patients with local and operable esophageal cancer.

97 l, postmenopausal women with newly diagnosed operable estrogen receptor-positive, human epidermal gro

98 junction with the microfluidic device and is operable even with a reversible seal.

99 tion creates two connected yet independently operable fluidic loops.

100 3 lymphadenectomy) in patients affected with operable gastric carcinoma?

101 In patients with operable gastric or lower esophageal adenocarcinomas, a

102 perioperative chemotherapy plus surgery for operable gastroesophageal cancer from July 1, 1994, thro

103 urrence-free survival (RFS) of patients with operable gastrointestinal stromal tumor (GIST) compared

104 protocol using paclitaxel with cisplatin in operable head and neck cancers have been reported.

105 men aged 18 years or older with stage I-IIIa operable HER2-positive breast cancer from 112 centres in

106 th an ECOG performance status of 0 or 1 with operable HER2-positive breast cancer.

107 Women with operable HER2-positive invasive breast cancer were rando

108 therapy would improve outcomes in women with operable, HER2-negative breast cancer and whether adding

109 enrolled women aged 18 years or older, with operable, HER2-non-amplified invasive adenocarcinoma of

110 Valve) I trial, 657 patients from cohort A (operable high risk) were randomly assigned to SAVR or TA

111 cohort B [inoperable] and 242 from cohort A [operable high-risk]) were randomly assigned to TF-TAVR a

112 s; HER2-amplified early stage breast cancer; operable, histologically confirmed, invasive carcinoma o

113 had performance status [PS] of 0 to 1) with operable, histologically confirmed, stage I to III adeno

114 ndomly assigned 257 premenopausal women with operable hormone-receptor-negative breast cancer to rece

115 omplete response in the breast in women with operable, human epidermal growth factor receptor 2 (HER2

116 These accumulation defects also appear operable in acute lymphoblastic leukemia.

117 ve useful in dissecting the molecular events operable in the development of neoplasms induced by bact

118 cates that an oxidative quenching pathway is operable in this broadly applicable fluorination protoco

119 s that two discrete reaction pathways can be operable in this process depending upon the nature of th

120 sponse to glycosylation inhibition, which is operable in WEHI7.2 cells.

121 evaluated NAC use in patients with initially operable invasive breast cancer and potential impact on

122 nts were eligible if they had stage I to III operable invasive breast cancer with complete surgical e

123 n 70 years from a consecutive series of 1944 operable invasive breast cancers.

124 To test this theory, 68 patients with 69 operable invasive breast carcinomas and clinically node-

125 ning biopsies from 483 patients with primary operable invasive ductal breast cancer was stained by im

126 brain metastases in patients with clinically operable known or possible NSCLC and a large (> 3-cm) lu

127 Patients with operable, localized gastric, or gastroesophageal adenoca

128 ality/trimodality treatment of patients with operable locally advanced non-small-cell lung cancer.

129 ntre using dynamic allocation, stratified by operable, locally advanced, and inflammatory breast canc

130 ntify the first station of nodal drainage of operable lung cancers.

131 e-free and overall survival among women with operable lymph-node-positive breast cancer.

132 leted in 15 min, the technique results in an operable microdevice with micrometer-scale features of n

133 Patients with operable node-positive BC (T1-3/N1-3) were eligible.

134 Cytoxan) improves survival in patients with operable node-positive disease.

135 We randomly assigned 5351 patients with operable, node-positive, early-stage breast cancer to re

136 ned to investigate whether, in patients with operable non-small cell lung cancer of any stage, outcom

137 een the standard treatment for patients with operable non-small-cell lung cancer (NSCLC).

138 chemotherapy after surgery for patients with operable non-small-cell lung cancer improves survival, i

139 gated the effect of adjuvant chemotherapy in operable non-small-cell lung cancer.

140 icin and cisplatin might produce survival of operable, non-metastatic osteosarcoma similar to that ob

141 407 patients with operable, non-metastatic osteosarcoma were randomly assi

142 ween the two-drug and multi-drug regimens in operable, non-metastatic osteosarcoma.

143 ere those with clinical T1-2a (<4 cm), N0M0, operable NSCLC.

144 ced 25 spatially distinct regions from seven operable NSCLCs and found evidence of branched evolution

145 emonstrated that two distinct mechanisms are operable on metallic Cu electrodes in acidic electrolyte

146 ents who are considered operable or probably operable on the basis of computed tomography and in the

147 th ER-positive, invasive, nonmetastatic, and operable or locally advanced potentially operable breast

148 otomy staging of patients who are considered operable or probably operable on the basis of computed t

149 s a disease that presents late and rarely is operable or resectable.

150 inical trial of neoadjuvant chemotherapy for operable osteosarcoma and the experience of two groups w

151 mised studies comparing SABR with surgery in operable patients are warranted.

152 Operable patients did not differ from nonoperable patien

153 From 1995 to 2009, 222 operable patients had a cCR based on the results of a co

154 After complete urologic evaluation, operable patients who achieved complete response were se

155 Initially, operable patients with early-stage NSCLC (n = 15) were e

156 Operable patients with localized gastric adenocarcinoma

157 Operable patients with locally advanced esophageal cance

158 once regarded as the treatment of choice in operable patients with massive hemoptysis.

159 High-risk operable patients with NSCLC </= 3 cm were randomly assi

160 emotherapy and to salvage the occasional non-operable patients with recurrent and chemoresistant dise

161 Fourteen operable patients with residual tumor underwent immediat

162 ents, and a recommended therapy in high-risk operable patients with symptomatic severe aortic stenosi

163 7 per patient but misses 1.7% of potentially operable patients.

164 therapy of choice for acute cholecystitis in operable patients.

165 R in carefully selected high-risk, but still operable, patients in whom morbidity and mortality may b

166 Women (N = 2,411) with operable primary breast cancer were randomly assigned to

167 therapy, chemotherapy), in the management of operable primary breast cancer with ostensibly good prog

168 for radiologically staged, locally advanced operable primary colon cancer is feasible with acceptabl

169 inflammatory response (SIR) in patients with operable primary colorectal cancer (CRC).

170 nts with centrally confirmed triple-negative operable primary invasive breast cancer from 360 sites i

171 unctional desensitization in the same set of operable receptors.

172 Local recurrence rates in operable rectal cancer are improved by radiotherapy (wit

173 pathological protocol in 1156 patients with operable rectal cancer from the CR07 and NCIC-CTG CO16 t

174 eatment is feasible in poor-risk potentially operable rectal cancer, with acceptable safety and promi

175 he risk of local recurrence in patients with operable rectal cancer.

176 is an effective treatment for patients with operable rectal cancer.

177 section is considered standard treatment for operable rectal carcinoma, the optimal time to administe

178 m 1988 to 1994, 68 patients with potentially operable squamous cell carcinoma of the esophagus were e

179 sed, phase 3 trials of SABR in patients with operable stage I NSCLC (STARS and ROSEL) closed early du

180 SABR could be an option for treating operable stage I NSCLC.

181 ative pazopanib monotherapy in patients with operable stage I/II NSCLC.

182 ng of clinical stage IIA and IIB and primary operable stage IIIA breast cancer?

183 hemoradiotherapy, surgery) for patients with operable stage IIIA non-small-cell lung cancer (NSCLC).

184 fter mediastinoscopic staging, patients with operable stage IIIA NSCLC were enrolled to a German mult

185 from a group of 315 patients suffering from operable (stage I and II) breast cancer with 20-years fo

186 The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is

187 noperable status (in 2011) and high-risk but operable status (starting in 2012).

188 ns the standard of care for the treatment of operable, symptomatic aortic valve disease; however, to

189 ts either died suddenly (n = 4) or developed operable symptoms only (n = 22) or subnormal LV performa

190 were compared: Cohort A patients (high-risk operable) treated by either TAVR (n = 149) or surgical a

191 ease-free (DFS) and overall survival (OS) in operable triple-negative breast cancer (TNBC).

192 ceptable alternative to women with palpable, operable tumors and an excellent arena for clinical tria

193 Surgery remains the treatment of choice for operable tumors, whereas chemotherapy is standard in loc

194 nnel blockade, if indicated; and surgery, if operable) were treated with chronic PGI2.